Tower of London test
From Psy3241
| Line 1: | Line 1: | ||
[[Category:Neuropsychological methods]] | [[Category:Neuropsychological methods]] | ||
| - | The Tower of London test is a widely used neuropsychological task that | + | The Tower of London test is a widely used neuropsychological task that assesses a person's planning ability and executive funtions. This test was developed by Shallice in 1982 to investigate problem solving in subjects with damage to the frontal lobes and executive functions of visuospatial planning and problem solving. It was originally designed for adults and later children and an emphasis is on spatial working memory. |
| - | The Tower of London test consists of a board with usually 4 pegs and several colored beads. The person being examined is given an arrangement of the beads that they are to duplicate in as few moves as possible. | + | The Tower of London test consists of a board with usually 4 pegs and several colored beads. The person being examined is typically given an arrangement of the beads that they are to duplicate in as few moves as possible. |
| + | |||
| + | This test is most commonly used on people with frontal lobe damage and has been used to test people with [[Alzheimer's disease]] and [[Schizophrenia]]. | ||
Revision as of 02:27, 23 April 2008
The Tower of London test is a widely used neuropsychological task that assesses a person's planning ability and executive funtions. This test was developed by Shallice in 1982 to investigate problem solving in subjects with damage to the frontal lobes and executive functions of visuospatial planning and problem solving. It was originally designed for adults and later children and an emphasis is on spatial working memory.
The Tower of London test consists of a board with usually 4 pegs and several colored beads. The person being examined is typically given an arrangement of the beads that they are to duplicate in as few moves as possible.
This test is most commonly used on people with frontal lobe damage and has been used to test people with Alzheimer's disease and Schizophrenia.
